What is the recommended management for an intertriginous fungal infection of the abdominal skin folds?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Fungal Infection in Abdominal Skin Folds

Apply topical azole antifungals (clotrimazole, miconazole, ketoconazole, oxiconazole, or econazole) twice daily to the affected abdominal folds for 7-14 days, continuing for at least one week after clinical resolution, while keeping the area dry—the single most important intervention for successful treatment. 1, 2

First-Line Topical Treatment

  • Topical azoles are the primary treatment recommendation from the Infectious Diseases Society of America, with clotrimazole and miconazole demonstrating cure rates of 80-85% in intertriginous candidal infections. 1

  • Nystatin (a polyene antifungal) is equally effective as an alternative, achieving complete cure rates of 73-100% in patients with candidal skin infections in body folds. 1

  • Treatment duration should be 7-14 days minimum, with continuation for at least one week after all visible signs have cleared to prevent recurrence. 1

Critical Non-Pharmacologic Measures

Keeping the infected area dry is the most important intervention—more critical than the choice of antifungal agent itself. 1, 2, 3

  • Patients should wear light, nonconstricting, absorbent clothing and avoid wool and synthetic fibers. 4

  • Avoid hot showers and excessive soap use, which promote skin dehydration and worsen inflammation. 1

  • Do not use alcohol-containing lotions or greasy creams on inflamed intertriginous skin, as these create an occlusive environment promoting folliculitis; instead use oil-in-water creams or ointments. 1

  • Patients should shower after physical activity and thoroughly dry intertriginous areas. 4

When to Escalate to Oral Therapy

Consider oral fluconazole 100-200 mg daily for 7-14 days when topical therapy fails or disease is extensive. 1, 2, 3

  • This is particularly important for patients with obesity, diabetes mellitus, or immunocompromised status, who require more aggressive management. 2, 3

  • Itraconazole solution 200 mg daily is an alternative oral option for resistant cases. 2, 3

Special Considerations for High-Risk Patients

Optimize glycemic control in diabetic patients, as the American Diabetes Association and Infectious Diseases Society of America recommend this to prevent recurrence of fungal intertrigo. 1

  • Obesity and diabetes create persistent moisture in skin folds, making these patients more prone to treatment failure. 2, 3

  • Maintenance therapy with intermittent topical antifungal application should be considered for recurrent cases. 2, 3

Important Pitfalls to Avoid

Never use topical corticosteroids without dermatologic supervision in intertriginous areas, as prolonged use carries significant risk of skin atrophy in these thin-skinned regions. 1

  • If bacterial superinfection is suspected (increased pain, purulent discharge, rapid worsening), add topical mupirocin or clindamycin lotion. 2, 3

  • For MRSA involvement, consider doxycycline or trimethoprim-sulfamethoxazole. 2, 3

  • Clotrimazole powder (1% CP) can be used as adjuvant therapy and shows significantly higher complete cure rates within four weeks compared to cream alone, especially for dermatophyte infections. 5

References

Guideline

Treatment for Skin Fungal Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Intertrigo Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Intertrigo Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Intertrigo and common secondary skin infections.

American family physician, 2005

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.